You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Hetero Labs Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for HETERO LABS, and what generic and branded alternatives to HETERO LABS drugs are available?

HETERO LABS has one hundred and forty-four approved drugs.

There are nine tentative approvals on HETERO LABS drugs.

Summary for Hetero Labs

US Patents:	0
Tradenames:	119
Ingredients:	117
NDAs:	144
Patent Litigation for Hetero Labs:	See patent lawsuits for Hetero Labs

Drugs and US Patents for Hetero Labs

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hetero Labs Ltd Iii	TADALAFIL	tadalafil	TABLET;ORAL	209908-001	Mar 26, 2019	AB1	RX	No	No		⤷ Sign Up				⤷ Sign Up
Hetero Labs Ltd V	LENALIDOMIDE	lenalidomide	CAPSULE;ORAL	212414-006	May 11, 2023	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Hetero Labs Ltd V	LACOSAMIDE	lacosamide	TABLET;ORAL	204787-003	Mar 17, 2022	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Hetero Labs Ltd V	QUETIAPINE FUMARATE	quetiapine fumarate	TABLET;ORAL	204316-006	Jun 16, 2022	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Hetero Labs Ltd V	ACYCLOVIR	acyclovir	TABLET;ORAL	203834-002	Oct 29, 2013	AB	RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Hetero Labs Ltd V	ESZOPICLONE	eszopiclone	TABLET;ORAL	205504-003	Jan 4, 2024	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for HETERO LABS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.